Anticipated Shortage

PRIORIX-TETRA

GLAXOSMITHKLINE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PRIORIX-TETRA in Canada?

A shortage of PRIORIX-TETRA 25118.9CCID50 1000CCID50 1995.2623PFU 1000CCID50 is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 30, 2026), but it has not started yet.

Why is PRIORIX-TETRA not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PRIORIX-TETRA be available again?

The manufacturer's estimated resolution date is December 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Expected resolution~33 days remaining (estimate)

Affected strength25118.9CCID50 1000CCID50 1995.2623PFU 1000CCID50

Report last updated2026-10-30

Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-12-15

~33 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02297884

Strength

25118.9CCID50 1000CCID50 1995.2623PFU 1000CCID50

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAMUSCULAR

Active Ingredient

MUMPS VIRUS LIVE ATTENUATED MEASLES VIRUS LIVE ATTENUATED VARICELLA-ZOSTER VIRUS LIVE ATTENUATED RUBELLA VIRUS LIVE ATTENUATED

Tier

Unrated

Last Updated

2026-10-30

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GLAXOSMITHKLINE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02245127

DIN 02245126

DIN 02240835

DIN 02240836

DIN 02240837

1MG · DIN 02237820